IP Library Granted Patent US 8,722,617
Granted Patent B2
US 8,722,617 · App. 12/344,773 · Granted May 13, 2014

Mussel adhesive protein derived vectors for gene delivery

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,722,617
App. No.
12/344,773
Granted
May 13, 2014
Kind
B2
Abstract

The present invention is related to a composition and a method for delivering a nucleic acid into a cell. The invention also provides a biocompatible and biodegradable gene delivery composition and methods of use and making thereof.

Claims (12)

1. A method for delivering a nucleic acid-fusion protein complex into a eukaryotic cell, said method comprising

contacting a eukaryotic cell with a complex comprising a nucleic acid and a fusion protein, wherein the fusion protein comprises the formula X-(FP-5)-X, where each X is the same and is chosen from the group consisting of FP-1, FP-2, FP-3, FP-4, FP-6 and SEQ ID NO: 2, and

wherein subsequent to the contacting step, the complex enters the eukaryotic cell.

2. The method of claim 1 , wherein the gene-delivering peptide further comprises nuclear localization signal peptide or a protein transduction domain.

3. The method of claim 1 , wherein the gene-delivering peptide further comprises a purification tag.

4. The method of claim 1 , wherein X=FP-1.

5. The method of claim 4 , wherein the fusion protein comprises SEQ ID NO:3.

6. The method of claim 1 , wherein X=FP-3.

7. The method of claim 6 , wherein the fusion protein comprises SEQ ID NO:5.

8. The method of claim 1 , wherein the cells are contained in a solution containing a calcium compound.

9. The method of claim 1 , wherein the weight ratio of the fusion protein to the nucleic acid is 1:1 to 100:1.

10. The method of claim 1 , wherein the nucleic acid is one selected from the group consisting of a genomic DNA, an RNA, an oligonucleotide, and an antisense nucleic acid.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 4, 2023
From: POSCO HOLDINGS INC.; POSTECH ACADEMY-INDUSTRY FOUNDATION
To: POSCO CO., LTD; POSTECH ACADEMY-INDUSTRY FOUNDATION
Reel/Frame 063254/0853 →
CHANGE OF NAME Recorded Sep 28, 2022
From: POSCO
To: POSCO HOLDINGS INC.
Reel/Frame 061562/0041 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2008
From: HWANG, DONG SOO; CHA, HYUNG-JOON
To: POSTECH ACADEMY-INDUSTRY FOUNDATION; POSCO
Reel/Frame 022032/0376 →